Verizon (VZ) EVP Kyle Malady receives new phantom stock award

Rhea-AI Filing Summary

Malady Kyle reported acquisition or exercise transactions in this Form 4 filing.

Verizon Communications executive Kyle Malady received a grant of phantom stock units through a deferred compensation plan. On this date, 120.397 unitized phantom stock awards were credited at a reference value of $14.44 per unit, economically tied to 34 shares of Verizon common stock.

Following this grant and related dividend reinvestment, Malady’s deferred compensation account reflects 410,521.482 phantom stock units held indirectly through the plan. These units are settled in cash and become payable upon events the executive previously established under the deferred compensation program, rather than through open-market share purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Malady Kyle

Role EVP and Group CEO-VZ Business

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (unitized)	120.397	$14.44	$2K

Holdings After Transaction: Phantom Stock (unitized) — 410,521.482 shares (Indirect, By Deferred Compensation Plan)

Footnotes (1)

1. Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan. Includes phantom stock acquired through dividend reinvestment.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (unitized)	(1)	03/12/2026		A		120.397		(1)	(1)	Common Stock	34	$14.44	410,521.482(2)	I	By Deferred Compensation Plan

Explanation of Responses:

1. Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.

2. Includes phantom stock acquired through dividend reinvestment.

Remarks:

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Verizon (VZ) report for Kyle Malady?

Verizon EVP and Group CEO-VZ Business Kyle Malady received 120.397 unitized phantom stock awards. These compensation-related units are economically tied to company stock and are credited to his deferred compensation plan rather than acquired through open-market share purchases.

How many Verizon phantom stock units does Kyle Malady hold after this award?

After the latest phantom stock award, Kyle Malady’s deferred compensation account shows 410,521.482 phantom stock units. This total includes the new 120.397 units and additional units accumulated over time, including amounts acquired through dividend reinvestment within the plan.

Are Kyle Malady’s Verizon phantom stock units paid in stock or cash?

Each Verizon phantom stock unit is economically equivalent to a portion of one common share but is settled in cash. Payment occurs upon specific events Malady established under the company’s deferred compensation plan, rather than delivering actual Verizon shares.

What is the reference price for Kyle Malady’s new Verizon phantom stock grant?

The 120.397 Verizon phantom stock units credited to Kyle Malady’s deferred compensation plan use a reference value of $14.44 per unit. This price is used for accounting the grant’s value and does not represent an open-market purchase or sale of Verizon shares.

Does Kyle Malady’s Verizon Form 4 show any stock sales or open-market buys?

The reported activity reflects a grant of 120.397 phantom stock units, not an open-market stock purchase or sale. These units are part of a deferred compensation arrangement and are settled in cash according to plan terms, rather than traded on the market.

How are dividends handled for Kyle Malady’s Verizon phantom stock units?

The phantom stock total for Kyle Malady includes amounts acquired through dividend reinvestment. When Verizon pays dividends, equivalent values are credited as additional phantom stock units in his deferred compensation account, increasing the overall phantom balance over time.